Bio

Charles Chau has represented clients in more than 100 public and private company acquisitions, joint ventures, financings, and pre-IPO investments. He advises on M&A, capital markets (including listings and public offerings), securities regulatory compliance, joint ventures, and other commercial transactions across Hong Kong, mainland China, and the Asia-Pacific region. Charles has 20 years of extensive experience in a wide variety of industry sectors, including banking and financial services, health care, biotech, retail, real estate, and manufacturing. He also has represented Chinese companies on their outbound acquisitions in the United States. Prior to joining Jones Day in 2017, Charles acted for China CNR Corporation Limited in its US$26 billion merger with CSR Corporation Limited, which was the first merger of two companies listed in both Hong Kong and Shanghai. In addition, he worked on many IPOs and securities placement transactions, including the IPOs of Sinopharm Group, China CNR Corporation, Guodian Technology & Environment Group, and the A+H rights issue of China CITIC Bank. Charles holds positions in several public organizations, including as an adjudicator of the Registration of Persons Tribunal and as a member of the Legal Committee and the Young Executive Club of the Hong Kong General Chamber of Commerce.